EMA prepares for major changes to European pharmacovigilance legislation
2 February 2012

New measures will encourage greater transparency and allow patients in any European Member State to report adverse reactions - 03/02/2012

 
Pillars of success in market access
26 January 2012

The key to true market access success begins with corporate ownership… - 02/02/2012

 
How to win through integrating market access
24 January 2012

Embedding and integrating market access strategies company-wide is key - 31/01/2012

 
Proving value in uncertain times
24 January 2012

Industry needs to be perceived as a contributor to healthcare solutions not just a cost - 01/02/2012

 
The role of systematic review in market access
23 January 2012

Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world?  - 30/01/2012

 
Were healthcare ads really that good in the 1980s?
23 January 2012

How centrally developed advertising campaigns can work in local markets and taking tips from motor industry campaigns can help increase brand engagement - 25/01/2012

 
Influence of iPad and mobile in pharma
19 January 2012

When Apple's Steve Jobs unveiled the iPad in early 2010, he probably did not anticipate that the tablet would challenge the business laptop market so quickly - 20/01/2012

 
Pinpoint precision in a brand plan review
11 January 2012

It is important to improve the risk-adjusted return on investment ratio when performing the annual brand plan review - 12/01/2012

 
Gain a deeper understanding of the product launch process
10 January 2012

Use best practices to create a cohesive strategy for a successful product launch, whether it is for a small molecule, biologic, vaccine or device - 13/01/2012

 
Miracles and mistakes in strategic planning
8 December 2011

What happens when we allow conscious thought and experience to cloud our thinking? - 06/01/2012

 

Questions? Tel: 0121 616 5051